Suppr超能文献

Notch激活在足细胞中的致病作用。

The pathogenic role of Notch activation in podocytes.

作者信息

Niranjan Thiruvur, Murea Mariana, Susztak Katalin

机构信息

Department of Medicine/Nephrology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Nephron Exp Nephrol. 2009;111(4):e73-9. doi: 10.1159/000209207. Epub 2009 Mar 17.

Abstract

Podocytes play a key role in the maintenance of the glomerular filtration barrier. Depletion or dysregulative mechanisms of podocytes can lead to the development of glomerulosclerosis. Signaling pathways that control these processes in podocytes are not fully understood. Recent studies from our and other laboratories found that genes that belong to the Notch pathway are regulated in patients and in animal models of renal disease. Genetic studies performed on mice with conditional expression of active Notch1 protein showed massive albuminuria, glomerulosclerosis, and ultimately renal failure and death of the animals. gamma-Secretase inhibitors and genetic deletion of Notch transcriptional binding partner (Rbpj) protected animals from nephrotic syndrome. Further studies are needed to define whether the activation of Notch pathway in podocytes represents a common pathomechanism in glomerular injury, and its potential to be a therapeutic target for the treatment of chronic kidney disease.

摘要

足细胞在维持肾小球滤过屏障中起关键作用。足细胞的耗竭或调节异常机制可导致肾小球硬化的发展。控制足细胞中这些过程的信号通路尚未完全了解。我们实验室和其他实验室最近的研究发现,在肾病患者和动物模型中,属于Notch通路的基因受到调控。对具有活性Notch1蛋白条件性表达的小鼠进行的基因研究显示,动物出现大量蛋白尿、肾小球硬化,最终肾衰竭并死亡。γ-分泌酶抑制剂和Notch转录结合伴侣(Rbpj)的基因缺失可保护动物免受肾病综合征的影响。需要进一步研究来确定足细胞中Notch通路的激活是否代表肾小球损伤的常见发病机制,以及其作为慢性肾脏病治疗靶点的潜力。

相似文献

1
The pathogenic role of Notch activation in podocytes.
Nephron Exp Nephrol. 2009;111(4):e73-9. doi: 10.1159/000209207. Epub 2009 Mar 17.
2
The Notch pathway in podocytes plays a role in the development of glomerular disease.
Nat Med. 2008 Mar;14(3):290-8. doi: 10.1038/nm1731. Epub 2008 Mar 2.
3
The role of Notch signaling in kidney podocytes.
Clin Exp Nephrol. 2017 Feb;21(1):1-6. doi: 10.1007/s10157-016-1247-y. Epub 2016 Feb 19.
4
Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
Dev Biol. 2011 Oct 15;358(2):318-30. doi: 10.1016/j.ydbio.2011.08.005. Epub 2011 Aug 16.
5
Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis.
Semin Nephrol. 2012 Jul;32(4):350-6. doi: 10.1016/j.semnephrol.2012.06.006.
7
Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Nat Commun. 2017 Sep 4;8(1):413. doi: 10.1038/s41467-017-00498-4.
8
Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Kidney Int. 2018 Apr;93(4):903-920. doi: 10.1016/j.kint.2017.11.014. Epub 2018 Feb 2.
9
The role of the podocyte in albumin filtration.
Nat Rev Nephrol. 2013 Jun;9(6):328-36. doi: 10.1038/nrneph.2013.78. Epub 2013 Apr 23.
10
Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury.
J Am Soc Nephrol. 2005 Dec;16(12):3611-22. doi: 10.1681/ASN.2005020167. Epub 2005 Nov 2.

引用本文的文献

1
Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1/Snail pathway.
BMC Nephrol. 2025 Apr 18;26(1):198. doi: 10.1186/s12882-025-04113-3.
2
Liraglutide Ameliorates Renal Endothelial Dysfunction in Diabetic Rats Through the Inhibition of the Dll4/Notch2 Pathway.
Diabetes Metab Syndr Obes. 2024 Oct 30;17:4091-4104. doi: 10.2147/DMSO.S492252. eCollection 2024.
3
The AKI-to-CKD Transition: The Role of Uremic Toxins.
Int J Mol Sci. 2023 Nov 10;24(22):16152. doi: 10.3390/ijms242216152.
4
Molecular pathways that drive diabetic kidney disease.
J Clin Invest. 2023 Feb 15;133(4):e165654. doi: 10.1172/JCI165654.
5
ADAMs family in kidney physiology and pathology.
EBioMedicine. 2021 Oct;72:103628. doi: 10.1016/j.ebiom.2021.103628. Epub 2021 Oct 12.
6
Sirtuins and Renal Oxidative Stress.
Antioxidants (Basel). 2021 Jul 27;10(8):1198. doi: 10.3390/antiox10081198.
8
Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria.
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001203.
9
Notch inhibitor mitigates renal ischemia‑reperfusion injury in diabetic rats.
Mol Med Rep. 2020 Feb;21(2):583-588. doi: 10.3892/mmr.2019.10857. Epub 2019 Dec 4.

本文引用的文献

1
Ectopic notch activation in developing podocytes causes glomerulosclerosis.
J Am Soc Nephrol. 2008 Jun;19(6):1139-57. doi: 10.1681/ASN.2007050596. Epub 2008 Mar 12.
2
The Notch pathway in podocytes plays a role in the development of glomerular disease.
Nat Med. 2008 Mar;14(3):290-8. doi: 10.1038/nm1731. Epub 2008 Mar 2.
3
Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.
Biochim Biophys Acta. 2008 Jan;1782(1):10-21. doi: 10.1016/j.bbadis.2007.09.005. Epub 2007 Oct 11.
4
Molecular insights into segmentation along the proximal-distal axis of the nephron.
J Am Soc Nephrol. 2007 Jul;18(7):2014-20. doi: 10.1681/ASN.2007040453. Epub 2007 Jun 13.
5
Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron.
Development. 2007 Feb;134(4):801-11. doi: 10.1242/dev.02773. Epub 2007 Jan 17.
6
7
Multiple functions of Notch signaling in self-renewing organs and cancer.
FEBS Lett. 2006 May 22;580(12):2860-8. doi: 10.1016/j.febslet.2006.03.024. Epub 2006 Mar 20.
8
Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression.
J Clin Invest. 2005 Nov;115(11):3166-76. doi: 10.1172/JCI25001. Epub 2005 Oct 20.
9
The Notch ligands DLL1 and JAG2 act synergistically to regulate hair cell development in the mammalian inner ear.
Development. 2005 Oct;132(19):4353-62. doi: 10.1242/dev.02002. Epub 2005 Sep 1.
10
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies.
Blood. 2005 Dec 1;106(12):3898-906. doi: 10.1182/blood-2005-01-0355. Epub 2005 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验